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Abstract
Background: Oct4 and Sox2 are two major transcription factors related to the stem cell self-renewal and
differentiation. The aim of this study was to examine the association between Oct4 and Sox2 expression levels with
both the clinicopathological characteristics and prognoses of patients with hypopharyngeal squamous cell
carcinoma.
Method: Tumor tissue samples from 85 patients with hypopharyngeal squamous cell carcinoma were collected,
and the clinical follow-up data of these patients were recorded, and expression status of Oct4 and Sox2 were
examined in these tissue samples by immunohistochemistry (IHC).
Results: Oct4 expression was found to be an independent predictive factor for overall survival (p = 0.004) in
patients with hypopharyngeal squamous cell carcinoma and was independently related to loco-regional control
(p = 0.001). Although Sox2 expression status showed no significant association with overall survival (p = 0.166),
disease-free survival (p = 0.680) or loco-regional control (p = 0.383), when using a subgroup analysis, the subgroup
with both high Oct4 and Sox2 expression had the best prognosis (p = 0.000). Sox2 expression could be a potential
prognostic predictor for patients with hypopharyngeal squamous cell carcinoma. Simultaneous analyses of Oct4
and Sox2 expression could be more effective in evaluating the prognoses of patients with hypopharyngeal
squamous cell carcinoma.
Conclusion: Oct4 expression is an independent predictive factor for patients with hypopharyngeal squamous cell
carcinoma, suggesting that Oct4 expression may be a useful indicator for predicting the prognosis of
hypopharyngeal squamous cell carcinoma.
Background
Head and neck squamous cell carcinoma, including
hypopharyngeal squamous cell carcinoma, is one of the
most common cancers worldwide and is associated with
low survival and high morbidity [1,2]. Characterized by
an aggressive growth pattern and lack of obvious early
symptoms, hypopharyngeal squamous cell carcinoma is
a cancer with the lowest survival rates among the head
and neck subsites [3,4]. Although the standard therapy
of surgery plus postoperative radiation results in a
5-year survival rate of 40-50%, most patients have non-
resectable tumors when they are diagnosed [5]. Interest-
ingly, the high mortality rate of patients is mainly due
to poor loco-regional control, including local tissue
invasion by the primary tumor and regional lymph node
involvement rather than distant metastasis [6].
The cancer stem cell (CSC) hypothesis posits that
tumors may be initiated and maintained by a subset of
cells that maintain or acquire stem-cell properties and
that each tumor contains a small subpopulation of cells
that have the ability to differentiate into multiple cell
lineages and self-renew [7,8]. Indeed, cancer stem cells or
cancer stem-like cells have been identified in several solid
tumor types such as breast cancer and colon cancer
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any medium, provided the original work is properly cited.[9,10]. This subpopulation is closely associated not only
with carcinogenesis, but also with recurrence and metas-
tasis of tumors [7]. However, there is no sufficient evi-
dence for putative cancer stem cells in hypopharyngeal
cancer, and this may be important to elucidate carcino-
genesis, to analyze prognosis, and to establish new thera-
peutic approaches for this cancer type.
Oct4 is a major member of the POU domain transcrip-
tion factors, which are required for the self-renewal char-
acteristics and differentiation potential of pluripotent
embryonic stem and germ cells [11,12]. Recent data show
that cells expressing high levels of Oct4 are present in
breast cancer, bladder cancer and oral squamous cell car-
cinoma and are associated with a worse prognosis [13-15].
Sox2 is also a major transcription factor belonging to
group B of the SOX family and is essential to maintain cell
proliferative potential. Unlike Oct4, Sox2 is also expressed
in some mature neurons [16,17]. On one hand, Sox2 can
promote the proliferation of breast cancers and gliomas
[18,19]. On the other hand, elimination of Sox2 can lead
to gastric cancer [20]. As a transcription factor in the Sox
family, Sox2 protein must bind with other proteins, such
as Oct4, to regulate DNA transcription [21,22]. In this
study, we evaluated Oct4 and Sox2 expression using
immunohistochemical staining of tumor tissues from
patients with hypopharyngeal squamous cell carcinoma
and analyzed the association between expression of Oct4/
Sox2, clinicopathological characteristics and prognosis of
hypopharyngeal squamous cell carcinoma.
Methods
Patients and tissue samples
This study was approved by the Institutional Review Board
and Human Ethics Committee of Sun Yet-sen University
Cancer Center. A total of 85 patients were included with
histologically confirmed squamous cell carcinoma of the
hypopharynx who were treated from 2002 to 2004 at the
Sun Yet-sen University Cancer Center. Relevant clinical
pathologic features (Table 1) were obtained from the
patients’ files and/or by telephone interviews with the
patient or their relatives. Tumor types and histological-
grade classifications were designated according to World
Health Organization classification of tumors: pathology
and genetics of head and neck tumors [23].
Immunohistochemistry (IHC) staining
Immunohistochemistry was performed on 4-μm-thick
routinely processed paraffin sections. Oct4 was detected
using a rabbit polyclonal anti-Oct4a antibody (Cell sig-
naling, #2890, UK, dilution 1:100). Sox-2 was detected
using a rabbit polyclonal anti-Sox antibody (Cell signal-
ing, #3579, UK, dilution 1:100). A total of 85 formalin-
fixed, paraffin-embedded hypopharyngeal squamous cell
carcinoma tissue samples were dried overnight at 56°C.
After deparaffinization and rehydration, sections were
heat-pretreated in a citrate buffer (92°C in microwave
oven) and incubated in 3% H2O2 to block endogenous
peroxidase activity. Then the sections were examined by
immunostaining using the primary antibodies overnight
at 4°C in a humidity chamber. The avidin-biotin
Table 1 The expressions of Oct4 and Sox2 and their
relationships with clinicopathological characteristics
Features No.
patients
OCT4 P
a SOX2 P
a
High Low High Low
Gender
Female 1 0 1 - 1 0 -
Male 84 14 70 66 18
Age (years)
b
<60 41 7 34 0.885 35 6 0.154
≥60 44 7 37 32 12
Histological grade
Well 34 5 29 0.572 28 6 0.030
Moderately 39 8 31 33 6
Poorly 12 1 11 6 6
SCCA
c (ng/ml)
≤ 1 43 8 35 0.348 34 9 0.794
>1 2 1 2 1 9 1 6 5
TSGF
d (ng/ml)
≤ 70 33 4 29 0.298 24 9 0.230
> 70 22 5 17 19 3
T Stage
1~2 21 3 18 0.756 16 5 0.734
3~4 64 11 53 51 13
Cervical lymph node metastasis
Positive 19 7 12 0.007 16 3 0.514
Negative 66 7 59 51 15
TNM Stage
I~II 7 1 6 0.871 4 3 0.143
III~IV 78 13 65 63 15
Treatment Type
e
L+N 7 5 2 - 5 2 -
L+N +R 4 1 3 3 1
L+N+C 4 1 3 3 1
L+N+R+C 6 0 6 2 4
N+R 2 0 2 1 1
N+R+C 6 2 4 4 2
R3 1 2 2 1
R + C 21 2 19 20 1
C 20 1 19 17 3
No treatment or
tracheotomy
12 1 11 10 2
a Chi-square test.
b Patients were divided according to the median values of age.
c SCCA, Squamous Cell Carcinoma Antigen.
d TSGF, Tumor Supplied Group of Factor.
e L = Laryngectomy, N = Neck dissection, R = Radiotherapy, C =
Chemotherapy.
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hematoxylin for nuclear counterstaining. Negative con-
trols were prepared by omitting the primary antibody.
Histological and IHC evaluation were independently per-
formed by two pathologists without knowledge of the
clinicopathological outcomes of the patients. Slides with
indeterminate evaluation were re-evaluated, and a con-
sensus was reached. Briefly, each slide was examined in
its entirety under a light microscope, and an initial score
was assigned which represented the estimated proportion
of positive tumor cells (0: none; 1: < 1/4; 2: 1/4 to 1/2; 3:
1/2 to 3/4; and 4: > 3/4). Next, an intensity score was
assigned which represented the average intensity of stain-
ing of the positive tumor cells (0, none; 1, weak; 2, inter-
mediate; and 3, strong). The proportion and intensity
scores were then added to obtain a total score, which
ranged from 0 to 7. Specimens were categorized into one
of two groups according to their overall scores: (1) low
expression, < 4 points; (2) high expression, 4-7 points.
Statistical methods
Statistical analysis was performed using the SPSS 17.0
software package for Windows. The c
2 test was used to
evaluate categorical variables. Associations between clin-
icopathological features and immunohistochemical Oct4
or Sox2 expression were analyzed using the logistic
regression model with the presence of overall survival as
the dependent variable. Multivariate survival analyses
were performed with the Cox regression model. Overall
survival (OS) was measured from the onset of treatment
to the date of death or the survival status at the last
date of follow-up. The loco-regional control (LRC) was
t h ei n t e r v a lf r o mt h eo n s e to ft r e a t m e n tt ot h ed a t eo f
recurrence. Recurrence was defined as local tissue inva-
sion by the primary tumor or regional lymph node
involvement. Disease-free survival (DFS) was defined as
the interval between the onset of treatment and the date
when recurrence or metastasis was diagnosed. OS, LRC
and DFS probabilities were estimated by the Kaplan-
Meier method and the significance of differences were
assessed by the log-rank test. A P-value < 0.05 was con-
sidered statistically significant, and a P-value < 0.01 was
considered strongly statistically significance.
Results
Clinicopathological features
Table 1 presents a summary of sex, age, tumor stage,
histological grade, and the status of SCCA (Squamous
Cell Carcinoma Antigen) as well as TSGF (Tumor
Supplied Group of Factor). In this study, there were 85
hypopharyngeal carcinoma patients consisting of 84
males and 1 female. The median age was 60 years
(range: 37-82 years). According to the 6th Edition of
the International Union Against Cancer (UICC) TNM
classification system, there were 7 Stage II patients,
24 Stage III patients, and 54 Stage IV patients, as
shown in Table 2. Recurrences were confirmed by his-
topathology or visual examination and were found to
have occurred in 72 patients. The median time to
Table 2 The relationships between clinicopathological
variables and immunohistochemical features with the
overall survival
Variables No.
patients
OS (%) P
a c
2
1y 3y 5y
Age
b (y)
<60 41 65.9 19.5 17.1 0.555 0.348
≥60 44 63.6 25.0 20.5
Histological grade
Well 34 66.7 25.0 25.0 0.996 0.008
Moderately 39 67.6 20.6 17.6
Poorly 12 61.5 23.1 17.9
SCCA
c (ng/ml)
≤ 1 43 69.8 18.6 16.2 0.200 1.639
> 1 21 71.4 19.0 14.3
TSGF
d (ng/ml)
≤ 70 33 69.7 15.2 12.1 0.244 1.356
> 70 22 68.2 22.7 18.2
T Stage
1~2 21 90.5 23.8 14.3 0.303 1.061
3~4 64 56.3 25.0 20.3
Cervical lymph
node metastasis
positive 66 63.6 18.2 15.2 0.103 2.662
negative 19 68.4 36.8 31.6
TNM Stage
I~II 7 100 28.5 28.5 0.678 0.173
III~IV 78 61.5 21.8 17.9
Oct4
e
High Expression 14 85.7 71.4 57.1 0.000 15.661
Low Expression 71 60.6 12.7 11.3
Sox2
e
High Expression 67 59.7 23.9 19.4 0.683 0.166
Low Expression 18 83.3 16.7 16.7
Oct4 & Sox2 0.000 17.991
Both high 13 88.2 76.9 61.5
Either high 55 54.5 10.9 9.1
Both low 17 82.4 17.6 17.6
a Log-rank test.
b Patients were divided according to the median values of age.
c SCCA, Squamous Cell Carcinoma Antigen.
d TSGF, Tumor Supplied Group of Factor.
e Two-sided log rank test with an overall sample size of 85 subjects (of which
71 are in group.
1 and 14 are in group 2) achieves 84% power at a 0.0500 significance level to
detect a difference of 0.5870 between 0.1270 and 0.7140–the proportions
surviving in groups 1 and 2,respectively. This corresponds to a hazard ratio of
0.1632. These results are based on the assumption that the hazard rates are
proportional.
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Seventy cancer-related deaths were reported. The med-
ian time to death was 17 months (range 0.16-74
months). The reasons for death were local recurrence
(62 patients), pulmonary metastases (3 patients), hepa-
tic or abdominal cavity metastases (3 patients) and
mediastinal metastases (2 patients).
Follow-up outcome
The last follow-up date is Sep. 29
th, 2009, with a median
follow-up time 52 months (range 7-69.5 months). The
1-, 3- and 5-year overall survival rates (OS) were 64.7%,
22.4%, 18.8%, respectively; disease-free survival (DFS)
was 24.7%, 15.3%, 12.9%, respectively. The local-regional
control rates were 24.7%, 16.5%, 15.3%, respectively.
Immunohistochemical expression of Oct4 or Sox2
Positive staining for Oct4 and Sox2, mainly localized in
the nucleus, were observed in the cancer cells of tumor
tissues (Fig. 1). The distribution of immunostaining
scores is listed in the Table 1. The highest expression
rate of Oct4 was 9.4% (8 of 85), whereas that of Sox2
was 71.8% (61 of 85). Furthermore, the expression
Oct4 is correlated with the cervical lymph node metas-
tasis (p = 0.007) whereas the expression of Sox2 is cor-
related with the histological grade (p =0 . 0 3 ) ,a si n
Table 1.
Association with prognosis
Univariate analyses showed no significant association
between OS, DFS or LRC and T stage, cervical lymph
node metastasis, TNM stage, age, or histological grade
(Table 2, 3). Patients with high Oct4 expression had a
significantly better prognosis, including longer survival
(p = 0.000) and lower recurrence rate (p = 0.000). Even
though Sox2 expression showed no association with
prognosis, the highest overall survival rate was docu-
mented in the high Oct4 expression/high Sox2 expres-
sion subgroup. The 5-years overall survival rate was
61.5% for this group (p = 0.000) (Fig. 2).
Figure 1 Expression of Oct4 and Sox2. Immunohistochemical staining for Oct4 and Sox2 expression in hypopharyngeal squamous cell
carcinoma. Brown grains represent a positive signal (3, 3-diaminobenzidine staining). The positive expression site of Oct4 and Sox2 was mainly
localized in the nucleus of tumor cells. (A) High Oct4 expression in tumor cells, (B) low Oct4 expression in tumor cells, (C) high Sox2 expression
in tumor cells, and (D) low Sox2 expression in tumor cells.
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A multivariate survival analysis was performed with the
Cox regression model for each predictor of prognosis to
calculate odds ratios, as well as 95% confidence intervals.
The model was simplified in a stepwise fashion by
removing variables that had a p value ≥0.05. Only three
variables remained statistically significant as independent
predictors of OS and LRC in the multivariate analysis.
Also, because the variable Oct4 & Sox2 expression con-
sisted of Oct4 expression and Sox2 expression, this vari-
able is replaced by Sox2 expression (Table 4). The results
indicate that the expression status of Oct4 (p = 0.004)
was an independent predictive factors for prognoses of
hypopharyngeal squamous cell carcinoma patients.
Discussion
The relationship between cancer cells and normal stem
cells is a hot topic in cell biology. There is evidence show-
ing that some cancer cells are functionally heterogeneous
Table 3 The relationships between clinicopathological
variables and immunohistochemical features with the
disease-free survival and the loco-regional control
Variables DFS LRC
P
a c
2 P
a c
2
Age
b 0.340 0.911 0.398 0.713
Histological grade 0.852 0.320 0.782 0.492
SCCA
c 0.265 1.243 0.165 1.932
TSGF
d 0.352 0.868 0.370 0.804
T Stage 0.437 0.605 0.567 0.328
Cervical lymph node metastasis 0.050 3.832 0.106 2.610
TNM Stage 0.877 0.024 0.934 0.007
Oct4 expression 0.000 22.275 0.000 20.405
Sox2 expression 0.680 0.170 0.383 0.761
Oct4 & Sox2 expression 0.000 26.331 0.000 22.101
a Log-rank test.
b Patients were divided according to the median values of age.
c SCCA, Squamous Cell Carcinoma Antigen.
d TSGF, Tumor Supplied Group of Factor.
Figure 2 The Kaplan-Meier survival curves. Kaplan-Meier curves for overall survival rates according to (A) Oct4 expression status, (B) Sox2
expression status, (C) combined expression status of Oct4/Sox2 and loco-regional control rates according to (D) Oct4 expression status in
hypopharyngeal squamous cell carcinoma. Statistical differences were calculated through log-rank comparisons.
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also of differentiation and maturation [7,8]. This subpopu-
lation of cancer cells may be similar to stem cells or stem-
like cells. Oct4 and Sox2 have been proven to be two
major transcription factors that can render an adult cell
capable of being reprogrammed to become a pluripotent
stem cell [12,24,25]. In addition, the expression of Oct4 or
Sox2 has been reported in the cancer stem-like cells and is
related to a cancer patient’s prognosis. Taken together,
Oct4 or Sox2 might play an important role in carcinogen-
esis and tumor progression and may be used as an indica-
tor of the patient prognosis [13-15,18,19].
In the present study, we found an association between
the expression of Oct4 and lymphoid metastasis, whereas
the expression of Sox2 was significantly related to the
histological grade of individual hypopharyngeal squa-
mous cell carcinomas. But expression of Oct4 and Sox2
had no significant association with the T stages. More
importantly, the status of Oct4 expression in tumor tis-
sues served as a significant independent predictor of both
OS and recurrence for the patients with hypopharyngeal
squamous cell carcinoma. This role as an independent
predictor was supported by data that patients with high
Oct4 expression survived longer and had a lower recur-
rence rates. Although the expression of Sox2 was not
associated with prognosis, the subgroup with high
expressions of both Oct4 and Sox2 presented the highest
5-year overall survival rate (61.5%) of all subgroups.
These data are supported by the fact that decreased
expression of Sox2 might be related to the carcinogenesis
human gastric epithelial cancers [26]. Thus, it may be not
surprising that high expression of Oct4 could be an indi-
c a t o ro fb e t t e rp r o g n o s i sf o rp a t i e n t sw i t hh y p o p h a r y n -
geal squamous cell carcinoma. In fact, in mouse
preimplantation embryos, Stewart CL showed that either
an increase above 150% or a decrease below 50% of the
endogenous Oct4 levels could serve as a trigger for the
differentiation of two somatic lineages, indicating that
Oct4 functions differently at lower or higher levels [27].
This may also apply for hypopharyngeal squamous cell
carcinoma, as shown in this manuscript. However, the
roles of Oct4 and Sox2 in hypopharyngeal squamous cell
carcinoma still require further investigation.
Conclusion
Currently, clinical TNM stage is insufficient to predict
prognoses of patients with hypopharyngeal squamous
cell carcinoma, patients of the same clinical stage often
show different clinical course. In this study we demon-
strate that Oct4 expression is an independent predictive
factor for patients with hypopharyngeal squamous cell
carcinoma, suggesting that Oct4 expression may be a
useful indicator for predicting the prognosis of hypo-
pharyngeal squamous cell carcinoma.
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